Evidence map›Paper›PMID 25112515›Full record

ArticleGenetic epidemiology2014

Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study.

Margaret M Parker, Marilyn G Foreman, Haley J Abel, Rasika A Mathias, Jacqueline B Hetmanski, James D Crapo, Edwin K Silverman, Terri H Beaty, COPDGene Investigators

Abstract read
In one paragraph

Article in Genetic epidemiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Characterisation of a COPD-associated nephronectin (The European respiratory journal · 2025
    Article
  4. Airway Mucus Plugs in Community-Living Adults: A Study Protocol.medRxiv : the preprint server for health sciences · 2024
    Article
  5. Article
  6. Airway Mucus Plugs in Community-Living Adults: A Study Protocol.Journal of clinical & experimental pathology · 2024
    Article
  7. Article
  8. Article
  9. Genetic Advances in Chronic Obstructive Pulmonary Disease. Insights from COPDGene.American journal of respiratory and critical care medicine · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Margaret M ParkerDepartment of Epidemiology, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland, United States of America.
Marilyn G Foreman
Haley J Abel
Rasika A Mathias
Jacqueline B Hetmanski
James D Crapo
Edwin K Silverman
Terri H Beaty
COPDGene Investigators
Johns Hopkins University · USBrigham and Women's Hospital · USJohns Hopkins Medicine · USMorehouse School of Medicine · USUniversity of Colorado Denver · USWashington University in St. Louis · US

Funding

Morehouse School of Medicine Center of Excellence Research Endowment ProgramS21MD000101 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI MONTGOMERY-RICE, VALERIE C. · 2001 to 2015
$74.3M
Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Metabolomic signatures of empysema and COPD progression in the COPDGene cohortR01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2012 to 2016
$31.1M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
(2 of 2) Genetic Epidemiology of COPDR01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2012 to 2016
$18.9M
Genetic Analysis of Susceptibility to COPD ExacerbationsK01HL092601 · NHLBI · MOREHOUSE SCHOOL OF MEDICINE · PI FOREMAN, MARILYN G. · 2008 to 2012
$711k
NHLBI NIH HHS K01 HL092601NHLBI NIH HHS K01HL092601NHLBI NIH HHS R01 HL089856NHLBI NIH HHS R01HL089856NHLBI NIH HHS R01 HL089897NHLBI NIH HHS R01HL089897NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897NIMHD NIH HHS S21 MD000101
6 · The paper itself

Abstract

African Americans are admixed with genetic contributions from European and African ancestral populations. Admixture mapping leverages this information to map genes influencing differential disease risk across populations. We performed admixture and association mapping in 3,300 African American current or former smokers from the COPDGene Study. We analyzed estimated local ancestry and SNP genotype information to identify regions associated with FEV1 /FVC, the ratio of forced expiratory volume in one second to forced vital capacity, measured by spirometry performed after bronchodilator administration. Global African ancestry inversely associated with FEV1 /FVC (P = 0.035). Genome-wide admixture analysis, controlling for age, gender, body mass index, current smoking status, pack-years smoked, and four principal components summarizing the genetic background of African Americans in the COPDGene Study, identified a region on chromosome 12q14.1 associated with FEV1 /FVC (P = 2.1 × 10(-6) ) when regressed on local ancestry. Allelic association in this region of chromosome 12 identified an intronic variant in FAM19A2 (rs348644) as associated with FEV1 /FVC (P = 1.76 × 10(-6) ). By combining admixture and association mapping, a marker on chromosome 12q14.1 was identified as being associated with reduced FEV1 /FVC ratio among African Americans in the COPDGene Study.

Indexed as

Black or African AmericanChemokines, CCChromosome MappingDisease SusceptibilityFemaleForced Expiratory VolumeGene FrequencyGenetic Association StudiesGenotypeHumansMaleMiddle AgedPolymorphism, Single NucleotidePulmonary Disease, Chronic ObstructiveQuantitative Trait LociRisk FactorsChemokines, CCTAFA2 protein, humanadmixture mappingAfrican AmericansCOPDlung function

Identifiers

PMID25112515
PMCPMC4190160
OpenAlexW2053097128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.